Henry N. Ginsberg, MD, is the Irving Professor of Medicine at Columbia University College of Physicians and Surgeons, Associate Dean for Clinical and Translational Research, and Director of the Irving Institute for Clinical and Translational Research at Columbia University Medical Center in New York, New York. He is the Principal Investigator of one of the first 12 NIH-funded Clinical Translational Science Awards (CTSA). Dr. Ginsberg earned his medical degree at the State University of New York Downstate Medical Center in Brooklyn, and completed training in internal medicine in the Boston University Service of the Boston City Hospital in Massachusetts. Dr. Ginsberg also trained in endocrinology and metabolism at Stanford University in California.
In addition to the CTSA grant, Dr. Ginsberg is principal investigator on two R01 research grants from the NIH, National Heart, Lung, and Blood Institute. He was also the co-principal investigator at Columbia on the ACCORD Trial and was the lead author on the ACCORD Lipid study published in the NEJM. His research interests have focused on the regulation of plasma cholesterol and triglyceride blood levels, particularly the metabolism of apolipoprotein B-containing lipoproteins in cells, mice, and humans. Much of his present work focuses on the interaction between insulin resistance, increased secretion of very low-density lipoproteins by the liver, and hepatic steatosis. Very active in clinical research training and education, Dr. Ginsberg was also program director of a T32 Postdoctoral Training Grant in Arteriosclerosis from 1993 until 2008, and then resumed the directorship in 2014. The CTSA has a predoctoral T32 program in translational research, a master's degree program in patient oriented research, and a junior faculty K12 Clinical Research Scholars Program.
Dr. Ginsberg actively participates in national organizations such as the American Heart Association (AHA) and the American Diabetes Association. He is a Fellow of the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology, and past chair of the AHA Leadership Committee. He is also a Fellow of the AHA Council on Nutrition, Physical Activity and Metabolism, a Fellow of the American Association for the Advancement of Science, as well as a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr Ginsberg is on the editorial boards of the Journal of Lipid Research, Arteriosclerosis, Thrombosis, and Vascular Biology, and the Journal of Metabolism. He has authored or coauthored more than 300 articles, reviews, and chapters related to lipids, diabetes, and heart disease.